Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Anticancer Research|February 7, 2016
Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal AdenocarcinomaEunsung Jun, Jaeyoon Jung, Seong-Yun Jeong, et al.
Journal for Immunotherapy of Cancer|February 27, 2023
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6Young Eun Lee, Ga-Yeon Go, Eun-Young Koh, et al.
Oncotarget|February 5, 2017
The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort studySang Hyun Shin, Hwa Jung Kim, Dae Wook Hwang, et al.
World Journal of Gastrointestinal Surgery|December 24, 2021
Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinomaSarang Hong, Ki Byung Song, Dae Wook Hwang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 11, 2022
Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft modelsSangmin Jeon, Eunsung Jun, Hyeyoun Chang, et al.
International Journal of Surgery (London, England)|September 1, 2022
Preoperative data-based deep learning model for predicting postoperative survival in pancreatic cancer patientsWoohyung Lee, Hyo Jung Park, Hack-Jin Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2020
Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatmentYoung Eun Lee, Anna Ju, Hwi Wan Choi, et al.
Cells|August 12, 2022
The Outcomes and Quality of Pancreatic Islet Cells Isolated from Surgical Specimens for Research on Diabetes MellitusJu Yun Oh, Yang Hee Kim, Song Lee, et al.
Annals of Surgery|June 16, 2021
Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal AdenocarcinomaSatoshi Nishiwada, Ya Cui, Masayuki Sho, et al.
Journal of Clinical Medicine|May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic CancerWoohyung Lee, Yejong Park, Jae Woo Kwon, et al.
Pageof 8